Announced Sat, 25 Jul · 15:39 IST
Board meeting on 1 Aug 2026 to approve Q1 FY27 financial results
Results View source PDF
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹385.95
prior close
₹385.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.9+1.2+1.8——————————
Up moveDown movePending
AI summary
SMS Pharmaceuticals has informed BSE that its Board of Directors will meet on 1 August 2026 at the registered office in Hyderabad. The board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The trading window for insiders was closed from 1 July 2026 and will reopen on 4 August 2026.
Likely market impact
Routine intimation. Q1 FY27 results expected after the board meeting on 1 August 2026; watch for revenue and profit growth numbers.